ClinicalTrials.gov
public full text
Public Domain
Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma
This is a phase II placebo-controlled intervention trial assessing aspirin (ASA) as a UV protectant in patients at risk for melanoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners#893875
- Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection#901418
- Restraint of melanoma progression by cells in the local skin environment.#327056
- The Effect of Violet Device Dosed Ultra Violet-C Light (UV-C) Exposure on Healthy Hand Skin#967842
- Passive Versus Active Educational Interventions for Melanoma Recognition#847483
Record · ID 847620
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive